Clinical Talks: AI for Breast Cancer Risk Prediction
Datum
-
Plats
Arr: SciLifeLab, digital meeting
Optimizing product protection – IP protection and regulatory exclusivity for new drugs
-
How can you create a solid and long market exclusivity for your new medicines? How do you keep the competition at bay to get more than just your investment back? Welcome to a seminar where you will learn more about how you best combine strategies for IP protection and regulatory exclusivity.
Congenital immunodeficiency and precision medicine
Datum
-
Plats
Arr: GMS, webbinarium
“The wealth of resources and opportunities gives endless possibilities”
The pioneering deeptech start-up Akira Science creates innovative medical device solutions, focusing on developing a new approach to breast reconstruction surgery. Winning Silicon Vikings New Nordics Pitch Competition opened doors to connect with innovators, VC funds, and world-leading companies.
Fighting children's cancer enabled by ERC starting grant
Kasper Karlssons project aims to fight cancer in children. The goal is to find targeted therapies that complement the standard treatment of neuroblastoma patients and thereby help more children beat cancer.
In search for more efficient treatments for psychiatric disorders with ERC starting grant
Juan Pablo Lopez‘ research aims to understand how the psychedelic compound psilocybin may be used to treat psychiatric disorders. Why people respond differently to antidepressant treatment is one of the questions he’ll try to answer.
Lunchtalks: Is it time for the state to control healthcare?
Datum
-
Plats
Arr: Bayer, KI Science Park and Waters Corporation, Stockholm
Tech Tuesday with Stockholm University
Datum
-
Plats
Arr: Kista Science City, Kista
Networks in Precision Medicine
For companies in the Stockholm-Uppsala region
The use of precision medicine is increasing in clinical practice. More precise diagnostic methods and advanced therapies make treatments become more effective. The proper treatment can be given to the right patient at the right time, and early detection means that diseases can be prevented or mitigated.
Since 2023, there is a network for SMEs in precision medicine in the Stockholm-Uppsala region. Around 30 people from 17 different companies attended the network's first meeting. There was great interest in continuing with activities within the network, and the participants agreed on themes for future sessions. During 2024 four sessions took place with these themes:
- Karolinska Institutet's and Karolinska University Hospital's investments in precision medicine
- Clinical trials
- Research infrastructure
- Forms of cooperation between companies of different sizes and between companies, industry and academia.
- ATMP – facilites, companies and competence in Flemingsberg.
If you wish to know more about the network, contact info@ssci.se
The network is within the Health Data Sweden (HDS) project, which aims to help small and medium-sized companies and the public sector digitize health data.
"Eliminating cancer requires a holistic approach"
EBBA HALLERSJÖ HULT: In Sweden, one out of three people will be diagnosed with cancer at some point in their lives. The disease causes suffering for the patient and entails a significant cost to society. Therefore, there is a great need for research and development to improve diagnostic methods and treatments. The solution is interdisciplinary collaborations between academia, healthcare, and industry – and working in a mission-oriented manner towards the same goal. Vision Zero Cancer has laid the foundation for a cross-border collaboration to renew cancer care.